NCT02629458View on ClinicalTrials.gov

A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Oncology
Interventions
PROCEDURE

Treatment by Surgical resection

PROCEDURE

Stereotactic Ablative Radiotherapy (SABR)

Trial Locations (1)

LS7 9TF

Leeds Teaching Hospitals NHS Trust, Leeds

All Listed Sponsors
lead

The Leeds Teaching Hospitals NHS Trust

OTHER

NCT02629458 - A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection | Biotech Hunter | Biotech Hunter